Immune-Mediated & Autoimmune Diseases
Immune-mediated and autoimmune diseases represent a diverse group of chronic, inflammatory disorders caused by dysregulation of the immune system. At Confidence Pharmaceutical Research, we are dedicated to advancing innovative therapies that restore immune balance, reduce inflammation, and improve quality of life for patients worldwide.
Our experience spans biologics, small molecules, and advanced immunotherapies targeting cytokines, receptors, and immune checkpoints. With operational expertise across early and late-phase studies, and strong collaborations with experienced investigators, we help sponsors accelerate the development of next-generation treatments in this evolving therapeutic area.
Focus Areas
- Rheumatoid Arthritis (RA)
- Evaluating biologic and targeted synthetic DMARDs for sustained disease control
- Systemic Lupus Erythematosus (SLE) & Lupus Nephritis
- Advancing immunomodulatory therapies to prevent organ damage and disease flares
- Psoriasis & Psoriatic Arthritis
- Assessing biologic and small-molecule therapies for inflammatory skin and joint disease
- Multiple Sclerosis (MS)
- Investigating immune-modulating and neuroprotective approaches
- Inflammatory Bowel Disease (Crohn’s Disease & Ulcerative Colitis)
- Exploring next-generation biologics and oral therapies for mucosal healing and long-term remission
- Asthma & Allergic Diseases
- Supporting development of targeted biologics and immunotherapies for allergic inflammation and airway control
- Atopic Dermatitis & Eczema
- Evaluating monoclonal antibodies and topical agents for improved skin barrier function and symptom relief